Company Comparison
Synthorx vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Synthorx | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | San Diego |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | Series A |
| Total Funding | — | $48M |
| Valuation | — | — |
What They Build
Synthorx
Biopharmaceutical company developing engineered protein therapeutics for cancer using expanded genetic code technology.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Synthorx
AI Therapeutics
No investors listed.
Sector Overlap
Both Synthorx and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
Sponsored
AArchstone
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees
Now in alpha with select funds. 14-day trial available.